Catalyseur Technologie Santé

Catalyseur Technologie Santé (CTS), commonly known as CTS Santé, is a health technology accelerator based in Montreal, Quebec, Canada. It describes itself as the growth catalyst dedicated to health technologies, offering a la carte acceleration, financing, and commercialization support. Its mission is to catalyze the growth of high-potential health technology startups through personalized support and privileged access to specialized resources, particularly during the critical stages of commercialization and financing. Its vision is to be the reference health technology accelerator in Quebec and Canada, with the goal of creating national champions that will help build the medicine of tomorrow. CTS operates programs divided into three themes: commercialization in Quebec/Canada, international commercialization, and pre-seed and seed financing. According to its website, it has been a specialized health technology accelerator for 15 years. Its programs are designed to be flexible and tailored to the needs of startups in the commercialization phase, rather than following a fixed cohort model. The Quebec/Canada commercialization program typically runs for one to two years and covers market knowledge, use-case validation, intellectual property strategy, regulatory strategy and roadmaps, access to key opinion leaders (KOLs) and scientific advisory boards, interoperability prerequisites, technological and clinical validation, and business model refinement. CTS positions itself as a reference accelerator in the health technology sector in Quebec and Canada. It works with startups and scale-ups in the health technology ecosystem, including companies such as AlayaCare, whose CEO and co-founder Adrian Schauer has publicly endorsed CTS as part of its ecosystem. Testimonials on the CTS website highlight its role in supporting financing rounds and commercialization of medical devices. The organization is headquartered in Montreal, Canada, and operates primarily in Quebec and Canada while also supporting international commercialization efforts.

Catalyseur Technologie Santé (CTS) is a health technology accelerator based in Montreal, Quebec, Canada. According to its website, it has been a specialized health technology accelerator for 15 years, though the exact founding year is not provided in the available evidence. The organization was established to support health technology startups in Quebec and Canada, with a mission to catalyze the growth of high-potential companies through personalized support and access to specialized resources. CTS operates on an a la carte model rather than a fixed cohort model, offering flexible programs tailored to the needs of startups in the commercialization phase. Its programs are divided into three themes: commercialization in Quebec/Canada, international commercialization, and pre-seed and seed financing. The Quebec/Canada commercialization program typically lasts one to two years and includes activities such as developing market knowledge, validating use cases and metrics, reviewing intellectual property strategy, developing regulatory strategies and roadmaps, identifying and facilitating access to key opinion leaders (KOLs), establishing scientific advisory boards, setting up technological prerequisites for interoperability, creating conditions for technological and clinical validation, and refining business models. The accelerator has worked with companies in the health technology ecosystem, including AlayaCare, a home care software provider. Adrian Schauer, CEO and co-founder of AlayaCare, has stated that AlayaCare is proud to be part of the CTS ecosystem and that CTS has been an essential player in the success of their financing round. CTS's vision is to be the reference health technology accelerator in Quebec and Canada, aiming to create national champions that will contribute to building the medicine of tomorrow. The organization is headquartered in Montreal, Canada, and operates primarily in Quebec and Canada while also supporting international commercialization efforts.

• CTS has been a specialized health technology accelerator for 15 years, according to its website.

A la carte health technology accelerator offering personalized support and privileged access to specialized resources for startups in commercialization and financing phases.

• Commercialisation Québec/Canada program

  A 1-2 year program to launch startups into their commercialization phase, covering market knowledge, use-case validation, IP strategy, regulatory strategy, KOL access, interoperability, technological and clinical validation, and business model refinement.

• Commercialisation internationale program

  A program focused on supporting startups in their international commercialization efforts.

• Financement de prédémarrage et démarrage program

  A program aimed at helping startups obtain pre-seed and seed financing.

1. 1CTS | Le catalyseur de croissance dédié aux technologies de la santéctssante.com
2. 2Quels sont les services offerts par CTS ?ctssante.com
3. 3Catalyseur Technologie Santéwikidata.org